scorecardresearch
Friday, August 29, 2025
TopicCovaxin

Topic: Covaxin

Give Covaxin only for second dose to 18-44 age group: Delhi govt directs private hospitals

Delhi govt said the direction will be applicable till further orders were issued. On Thursday, Delhi health department had issued the same order to all govt Covid vaccination centres.

Good news from vaccine study: Both work well, Covishield produces more antibodies than Covaxin

Study by Indian doctors says that while Covaxin & Covishield are effective, the AstraZeneca vaccine shows ‘significantly higher’ seropositivity rate & anti-spike antibody titre.  

Plea filed in Delhi HC seeking stay on phase 2/3 clinical trials of Covaxin on children

The petition has raised an apprehension that the children who would be part of the trial could suffer adverse health or mental effects due to the testing of the vaccine on them.

India looking forward to WHO’s nod for Bharat Biotech’s Covaxin, says Foreign Secretary

Foreign Secretary Harsh Vardhan Shringla Thursday said the govt has worked with key partners to ease regulatory disruptions to vaccine supply chains through diplomatic interventions.

Modi govt policy not effective enough, Covid vaccine must be free for all, ICMR researchers say

Two ICMR researchers author article that notes how slow roll out & shortages resulted in 3% population being vaccinated, says target of vaccinating a billion by year-end seems unlikely.

Delhi receives 48,000 Covaxin doses for people above 45 yrs, says AAP MLA Atishi

The national capital also received over 83,000 doses of Covishield Friday, said AAP MLA Atishi.

Covaxin production to be increased to 6-7 crore doses in July-August, health ministry says

The health ministry said the production capacity of Bharat Biotech's Covaxin is expected to reach nearly 10 crore doses a month by September.

It takes 4 months to manufacture, release a batch of Covaxin, says Bharat Biotech

Bharat Biotech’s statement comes at a time when the country is facing a shortage of Covid vaccines, leading to disruptions in the nationwide inoculation programme.

Bharat Biotech files new request to Brazilian regulator for GMP certification for Covaxin

The Good Manufacturing Practices certification of all stages of vaccine production is a prerequisite for the registration of the immuniser in Brazil.

Why health experts are wary of Bharat Biotech’s Covid vaccine trials on children

Paediatric trials, or those involving children, could be risky since the body is still developing & has different immunity levels. Experts say it requires careful ethical consideration.

On Camera

Mohan Bhagwat’s U-turn on ‘retire at 75’ is a Hindu succession problem

RSS chief Mohan Bhagwat has backtracked on his retirement rules. The ‘75-year rule’ was applied selectively to sideline some leaders, but it doesn’t apply to the top brass.

Easy loans, uneasy ‘debt traps’. Women harassed by private lenders ask ‘who will restore lost dignity?’

A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.

Post-Sindoor, joint doctrine tasks Special Forces with fighting info warfare & countering propaganda

Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.